A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration

Kidney Int. 2022 Nov;102(5):1188-1190. doi: 10.1016/j.kint.2022.07.022. Epub 2022 Aug 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Humans
  • Immunoglobulin G
  • Kidney Transplantation* / adverse effects
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus

Substances

  • spike protein, SARS-CoV-2
  • Spike Glycoprotein, Coronavirus
  • tixagevimab
  • cilgavimab
  • Immunoglobulin G